{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T11:14:54Z","timestamp":1782818094936,"version":"3.54.5"},"reference-count":52,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["21K20803"],"award-info":[{"award-number":["21K20803"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["22K16660"],"award-info":[{"award-number":["22K16660"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["24K12285"],"award-info":[{"award-number":["24K12285"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["21K16632"],"award-info":[{"award-number":["21K16632"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["22K16687"],"award-info":[{"award-number":["22K16687"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["23H03017"],"award-info":[{"award-number":["23H03017"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008643","name":"Japan Brain Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008643","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.isci.2025.113456","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T17:31:39Z","timestamp":1756402299000},"page":"113456","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Dual molecular therapy targeting tumor cell heterogeneity improves therapeutic efficacy in glioblastoma"],"prefix":"10.1016","volume":"28","author":[{"given":"Shuichiro","family":"Hirano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9709-6034","authenticated-orcid":false,"given":"Atsuhito","family":"Uneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1615-5125","authenticated-orcid":false,"given":"Yoshihiro","family":"Otani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuki","family":"Suruga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoji","family":"Imoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madoka","family":"Hokama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Umeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Ikemachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohei","family":"Nishigaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobushige","family":"Tsuboi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keigo","family":"Makino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Kemmotsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhito","family":"Kegoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Shimazu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joji","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Wakimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Date","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2025.113456_bib1","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2025.113456_bib2","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1001\/jama.2017.18718","article-title":"Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial","volume":"318","author":"Stupp","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.isci.2025.113456_bib3","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1001\/jamaoncol.2020.1024","article-title":"Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical Trial","volume":"6","author":"Reardon","year":"2020","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.isci.2025.113456_bib4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10014-022-00431-8","article-title":"Implications of immune cells in oncolytic herpes simplex virotherapy for glioma","volume":"39","author":"Otani","year":"2022","journal-title":"Brain Tumor Pathol."},{"key":"10.1016\/j.isci.2025.113456_bib5","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S1470-2045(17)30517-X","article-title":"Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial","volume":"18","author":"Weller","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.isci.2025.113456_bib6","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ccell.2017.06.003","article-title":"Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment","volume":"32","author":"Wang","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2025.113456_bib7","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/s41568-022-00486-x","article-title":"Brain cancer stem cells: resilience through adaptive plasticity and hierarchical heterogeneity","volume":"22","author":"Gimple","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.isci.2025.113456_bib8","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.stem.2016.11.003","article-title":"Adaptive Chromatin Remodeling Drives Glioblastoma Stem Cell Plasticity and Drug Tolerance","volume":"20","author":"Liau","year":"2017","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.isci.2025.113456_bib9","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1158\/0008-5472.CAN-22-0507","article-title":"\u03b22-Microglobulin Maintains Glioblastoma Stem Cells and Induces M2-like Polarization of Tumor-Associated Macrophages","volume":"82","author":"Li","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2025.113456_bib10","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.stem.2018.03.011","article-title":"Reciprocal Signaling between Glioblastoma Stem Cells and Differentiated Tumor Cells Promotes Malignant Progression","volume":"22","author":"Wang","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.isci.2025.113456_bib11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s40478-021-01124-7","article-title":"Differentiated glioblastoma cells accelerate tumor progression by shaping the tumor microenvironment via CCN1-mediated macrophage infiltration","volume":"9","author":"Uneda","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.isci.2025.113456_bib12","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa043331","article-title":"MGMT gene silencing and benefit from temozolomide in glioblastoma","volume":"352","author":"Hegi","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2025.113456_bib13","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/neuonc\/nox161","article-title":"Phase I\/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874\/ABTC 02","volume":"20","author":"Galanis","year":"2018","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.isci.2025.113456_bib14","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1002\/cncr.32340","article-title":"A phase 1 and randomized, placebo-controlled phase 2 trial of bevacizumab plus dasatinib in patients with recurrent glioblastoma: Alliance\/North Central Cancer Treatment Group N0872","volume":"125","author":"Galanis","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.isci.2025.113456_bib15","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/neuonc\/nov011","article-title":"Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627)","volume":"17","author":"Lassman","year":"2015","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.isci.2025.113456_bib16","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.cell.2014.02.030","article-title":"Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells","volume":"157","author":"Suva","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.isci.2025.113456_bib17","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41392-020-0110-5","article-title":"Targeting cancer stem cell pathways for cancer therapy","volume":"5","author":"Yang","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.isci.2025.113456_bib18","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/stem.1528","article-title":"A high Notch pathway activation predicts response to gamma secretase inhibitors in proneural subtype of glioma tumor-initiating cells","volume":"32","author":"Saito","year":"2014","journal-title":"Stem Cells"},{"key":"10.1016\/j.isci.2025.113456_bib19","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1158\/1078-0432.CCR-19-3420","article-title":"Oncolytic HSV-Infected Glioma Cells Activate NOTCH in Adjacent Tumor Cells Sensitizing Tumors to Gamma Secretase Inhibition","volume":"26","author":"Otani","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.isci.2025.113456_bib20","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/s41422-020-0338-1","article-title":"Three-dimensional bioprinted glioblastoma microenvironments model cellular dependencies and immune interactions","volume":"30","author":"Tang","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.isci.2025.113456_bib21","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.cell.2013.08.003","article-title":"An Interactive Resource to Identify Cancer Genetic and Lineage Dependencies Targeted by Small Molecules","volume":"154","author":"Basu","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.isci.2025.113456_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/cells10123327","article-title":"Regulation of Cell Cycle Progression by Growth Factor-Induced Cell Signaling","volume":"10","author":"Wang","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.isci.2025.113456_bib23","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.ccell.2021.03.010","article-title":"Targeting cell-cycle machinery in cancer","volume":"39","author":"Suski","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2025.113456_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108449","article-title":"Excessive E2F Transcription in Single Cancer Cells Precludes Transient Cell-Cycle Exit after DNA Damage","volume":"33","author":"Segeren","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2025.113456_bib25","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.cell.2013.09.034","article-title":"The somatic genomic landscape of glioblastoma","volume":"155","author":"Brennan","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.isci.2025.113456_bib26","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s10637-016-0372-5","article-title":"Molecular and cellular effects of a novel hydroxamate-based HDAC inhibitor - belinostat - in glioblastoma cell lines: a preliminary report","volume":"34","author":"Kusaczuk","year":"2016","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.isci.2025.113456_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/genes12020260","article-title":"Downregulation of Cell Cycle and Checkpoint Genes by Class I HDAC Inhibitors Limits Synergism with G2\/M Checkpoint Inhibitor MK-1775 in Bladder Cancer Cells","volume":"12","author":"Hoffmann","year":"2021","journal-title":"Genes"},{"key":"10.1016\/j.isci.2025.113456_bib28","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.3390\/cells11162508","article-title":"PI3K\/AKT\/mTOR-Targeted Therapy for Breast Cancer","volume":"11","author":"Zhu","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.isci.2025.113456_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.556532","article-title":"Dasatinib Inhibits Lung Cancer Cell Growth and Patient Derived Tumor Growth in Mice by Targeting LIMK1","volume":"8","author":"Zhang","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.isci.2025.113456_bib30","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-1-4939-0888-2_2","article-title":"Cell cycle regulation by checkpoints","volume":"1170","author":"Barnum","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.isci.2025.113456_bib31","article-title":"Rapamycin Enhances the Anti-Cancer Effect of Dasatinib by Suppressing Src\/PI3K\/mTOR Pathway in NSCLC Cells","volume":"10","author":"Chen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2025.113456_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.1093939","article-title":"Biological function, mediate cell death pathway and their potential regulated mechanisms for post-mortem muscle tenderization of PARP1: A review","volume":"9","author":"Li","year":"2022","journal-title":"Front. Nutr."},{"key":"10.1016\/j.isci.2025.113456_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/nu10060731","article-title":"Targeting Histone Deacetylases with Natural and Synthetic Agents: An Emerging Anticancer Strategy","volume":"10","author":"Singh","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.isci.2025.113456_bib34","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1093\/neuonc\/nov086","article-title":"Dasatinib in recurrent glioblastoma: failure as a teacher","volume":"17","author":"Schiff","year":"2015","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.isci.2025.113456_bib35","doi-asserted-by":"crossref","first-page":"688","DOI":"10.3390\/tomography8020057","article-title":"Final Report on Clinical Outcomes and Tumor Recurrence Patterns of a Pilot Study Assessing Efficacy of Belinostat (PXD-101) with Chemoradiation for Newly Diagnosed Glioblastoma","volume":"8","author":"Xu","year":"2022","journal-title":"Tomography"},{"key":"10.1016\/j.isci.2025.113456_bib36","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1182\/blood-2008-02-140665","article-title":"Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome\u2013positive leukemia","volume":"112","author":"Porkka","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.isci.2025.113456_bib37","doi-asserted-by":"crossref","first-page":"53","DOI":"10.18383\/j.tom.2018.00031","article-title":"Assessing Treatment Response of Glioblastoma to an HDAC Inhibitor Using Whole-Brain Spectroscopic MRI","volume":"5","author":"Gurbani","year":"2019","journal-title":"Tomography"},{"key":"10.1016\/j.isci.2025.113456_bib38","doi-asserted-by":"crossref","first-page":"W488","DOI":"10.1093\/nar\/gkaa216","article-title":"SynergyFinder 2.0: visual analytics of multi-drug combination synergies","volume":"48","author":"Ianevski","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2025.113456_bib39","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Aravind Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2025.113456_bib40","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nchembio.1986","article-title":"Correlating chemical sensitivity and basal gene expression reveals mechanism of action","volume":"12","author":"Rees","year":"2016","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.isci.2025.113456_bib41","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1158\/2159-8290.CD-15-0235","article-title":"Harnessing Connectivity in a Large-Scale Small-Molecule Sensitivity Dataset","volume":"5","author":"Seashore-Ludlow","year":"2015","journal-title":"Cancer Discov."},{"key":"10.1016\/j.isci.2025.113456_bib42","first-page":"1210","article-title":"FastQC: A Quality Control Tool for High Throughput Sequence Data","volume":"5","author":"Andrews","year":"2010","journal-title":"Cancer Discov."},{"key":"10.1016\/j.isci.2025.113456_bib43","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: a flexible trimmer for Illumina sequence data","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.isci.2025.113456_bib44","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nbt.3519","article-title":"Near-optimal probabilistic RNA-seq quantification","volume":"34","author":"Bray","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.isci.2025.113456_bib45","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature08460","article-title":"Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1","volume":"462","author":"Barbie","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.isci.2025.113456_bib46","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1158\/0008-5472.CAN-08-3886","article-title":"Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors","volume":"69","author":"Wakimoto","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2025.113456_bib47","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/neuonc\/nor195","article-title":"Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells","volume":"14","author":"Wakimoto","year":"2012","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.isci.2025.113456_bib48","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.cell.2013.08.003","article-title":"An interactive resource to identify cancer genetic and lineage dependencies targeted by small molecules","volume":"154","author":"Basu","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.isci.2025.113456_bib49","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/onc.2017.373","article-title":"Fibroblast growth factor 13 regulates glioma cell invasion and is important for bevacizumab-induced glioma invasion","volume":"37","author":"Otani","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.isci.2025.113456_bib50","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40478-020-00916-7","article-title":"Annexin A2-STAT3-Oncostatin M receptor axis drives phenotypic and mesenchymal changes in glioblastoma","volume":"8","author":"Matsumoto","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.isci.2025.113456_bib51","doi-asserted-by":"crossref","first-page":"7360","DOI":"10.1158\/1078-0432.CCR-17-1549","article-title":"CD90 Expression Controls Migration and Predicts Dasatinib Response in Glioblastoma","volume":"23","author":"Avril","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.isci.2025.113456_bib52","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ccell.2020.06.003","article-title":"Cell Lineage-Based Stratification for Glioblastoma","volume":"38","author":"Wang","year":"2020","journal-title":"Cancer Cell"}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225017171?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225017171?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T01:44:35Z","timestamp":1769651075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004225017171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":52,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2589004225017171"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2025.113456","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual molecular therapy targeting tumor cell heterogeneity improves therapeutic efficacy in glioblastoma","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2025.113456","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"113456"}}